Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 84.10B P/E 41.27 EPS this Y 9.00% Ern Qtrly Grth 13.90%
Income 2.34B Forward P/E 29.98 EPS next Y 11.20% 50D Avg Chg 6.00%
Sales 8.54B PEG 2.71 EPS past 5Y 10.28% 200D Avg Chg 11.00%
Dividend 1.00% Price/Book 18.73 EPS next 5Y 9.73% 52W High Chg -7.00%
Recommedations 1.80 Quick Ratio 1.77 Shares Outstanding 456.95M 52W Low Chg 47.00%
Insider Own 0.23% ROA 13.15% Shares Float 456.95M Beta 0.85
Inst Own 95.67% ROE 49.82% Shares Shorted/Prior 3.65M/3.77M Price 182.00
Gross Margin 70.06% Profit Margin 27.43% Avg. Volume 2,093,556 Target Price 221.70
Oper. Margin 32.17% Earnings Date May 2 Volume 2,074,218 Change -1.89%
About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS Chatroom

User Image DVM2Trader Posted - 12 hours ago

$ZTS updated weekly chart. 13 days until earnings. This should be just about done dumping. Curious to see what happens next week. Weekly volume candle is huge. No new adds today. Keeping a close eye on flow Into earnings. Gamma Is quite negative for this stock (well for much of the market too). Could see a decent gamma squeeze on any relatively positive news.

User Image badnewzva Posted - 15 hours ago

$ZTS Just go to zero for God’s sake 🤷🏽‍♂️

User Image MaverickGoose Posted - 20 hours ago

$ZTS Why is this tanking today?

User Image KabraxisX Posted - 20 hours ago

$ZTS

User Image insiderbuyingselling Posted - 1 day ago

$ZTS new insider selling: 923 shares. http://insiderbuyingselling.com/?t=ZTS

User Image DividendPower Posted - 1 day ago

The List of Dividend Contenders 2024 - Updated 04/18/24 https://www.dividendpower.org/list-dividend-contenders-2024/ $USB $HUBB $ZTS $NEP $CHDN

User Image JacoI3 Posted - 1 day ago

$HXL It appears I chose this stock at a bad time. It also appears that when congress files their trades and retail comes running the stocks tanks. Coincidence? Could be. Intentional? Could be. But it would make sense. Let retail pile in, take them for a swim, many doesn’t like being under water or runs out of air, then tutes or hedgies buys up what’s left behind and takes off without them. Yeah I’m looking at you $HUMA $PANW $ZTS $PFE and a few others

User Image KabraxisX Posted - 1 day ago

$ZTS

User Image DVM2Trader Posted - 2 days ago

$ZTS weekly candles. At ~26% this is the largest drawdown this stock has seen since the 2022 top. In total, from the Jan 2022 top to the October 2022 Top the stock saw a 50% drawdown. 150 Is the key level to hold/regain after monthly options expire this week. I'm expecting chop Into earnings unless the whole market decides to squeeze. I've already added this level and not looking to add more until there Is more clarity regarding the Interim bottom. Any adds additional should have a trailing stop loss to manage risk. This Is a long term commons hold In my ROTH.

User Image twycgnb Posted - 2 days ago

$ZTS giving it the rest of the week to hold above 150. If it does with no news over the weekend I'll be looking for a starter around 152.

User Image TryingToMakeABuck Posted - 2 days ago

$ZTS ok fellow investors, what's the consensus?

User Image Value_Amigo Posted - 2 days ago

$ZTS Earnings growth is slowing so why should it be trading at like 26 times forward earnings? Current analyst consensus estimates Dec 2024 Eps 5.78 forward p/e 26.46 maybe 22 times forward earning more appropriate for this solid company.

User Image micheln1 Posted - 2 days ago

$ZTS I’ve never seen this one so weak??? What’s going on??

User Image Ourfatherupthere Posted - 3 days ago

$ZTS no way this piece of s*** should be up this piece of s*** should be in the 110s

User Image DonCorleone77 Posted - 3 days ago

$ZTS Zoetis price target lowered to $195 from $220 at Piper Sandler Piper Sandler analyst David Westenberg lowered the firm's price target on Zoetis to $195 from $220 and keeps an Overweight rating on the shares. As the firm cautioned might happen in our recent veterinary survey note, the Wall Street Journal published an article last week highlighting social media posts and pet owner concerns over Librela. The article and expectations of its release have weighed heavily on the stock price. That said, Piper's checks find that veterinarians and practice owner groups continue to view Librela positively. The firm expects minimal impacts from social media concerns, but adjusted its model and price target to reflect what it believes is a bear case scenario for Librela.

User Image Zit1343 Posted - 4 days ago

$ZTS I told you

User Image pepe7 Posted - 4 days ago

$ZTS

User Image Pdq3 Posted - 4 days ago

$ZTS Took a small position on Friday with the FUD. From personal experience, Librela is a game changer for arthritis, and the article released stated nothing not known, and was pretty obviously planned based on the put buying days prior. Been waiting for this to get cheap.

User Image KabraxisX Posted - 4 days ago

$ZTS

User Image Deliquified Posted - 6 days ago

$ZTS Someone always knows...

User Image Aigner_Andreas Posted - 1 week ago

#DeathCross $ZTS at 149.98 R11 T1Y 226 buy 1.8 DIV 0.86% #Zoetis Inc #stocks #trading #finance #market

User Image DVM2Trader Posted - 1 week ago

$ZTS I’m a vet, I’ve been using these drugs for a while and spoken with colleagues about them as well. IMO when paired with appropriate patient selection and client education these drugs are life changing for senior pets. Just a lot of FUD and market manipulation going on. Side note: I can’t believe I missed them loading those puts on Thursday I would have jumped in 🤣🤦🏼‍♀️

User Image DVM2Trader Posted - 1 week ago

$ZTS I added today and put some bids in around 130 and 120 if they decide to keep dumping it. These biologics are just a tiny fraction of what this company does.

User Image victorcastro Posted - 1 week ago

$JPM $ZTS $SPY $CPNG $ANET

User Image cubie Posted - 1 week ago

$ZTS bit similar to $gl huh🙈😆😅

User Image cubie Posted - 1 week ago

@simon58 @mj_ryder @jenbunn @keywestave01 @kindness123 @TraderRapp @tonyctl @tigerknee @lukenight $zts lawsuits?🙈😅

User Image cubie Posted - 1 week ago

@kindness123 @simon58 @mj_ryder @jenbunn @keywestave01 @TraderRapp @tonyctl @tigerknee @lukenight yea $zts flatlined most day so most money was already made before markets opened kindness, but congrats those had puts yesterday 😅

User Image Investing_cents Posted - 1 week ago

$ZTS So I asked my sister, who has been a vet for 7 years, treating thousands of dogs with Solensia. She said "I've only had great results." The manupulation is so obvious, Short sales were high last week, followed by bs articles to drop the price with no evidence of anything significant to the company.

User Image tradethehalt Posted - 1 week ago

$ZTS Zoetis Stock Tumbles on Safety Concerns for Arthritis Shots for Pets https://www.marketwatch.com/story/zoetiss-stock-falls-7-to-lead-s-p-500-decliners-after-report-its-arthritis-shots-have-sickened-pets-cdef1d7d

User Image lecorb Posted - 1 week ago

$NUTX April 12, 2024 at 04:03 pm EDT Share (MT Newswires) -- Health care stocks were falling late Friday afternoon, with the NYSE Health Care Index sliding 1.6% and the Health Care Select Sector SPDR Fund (XLV) down 1.5%. The iShares Biotechnology ETF (IBB) lost 2.4%. In corporate news, Agenus ($AGEN) shares sank 9% after the company gave an update to its early-stage trial of BOT/BAL combination therapy in patients with metastatic colorectal cancer. PaxMedica ($PXMD) shares doubled after the company said late Thursday it reached an "important milestone" .... Zoetis ($ZTS) tumbled almost 8% after a Wall Street Journal's report on dog owners blaming the drugmaker's arthritis drug Librela for causing side effects to their pets. Nutex Health ($NUTX) said it has decided to place a moratorium on the opening of new hospitals this year and was considering the closure or sale of more underperforming facilities in the near future. Its shares dropped about 11%. https://www.marketscreener.com/quote/stock/AGENUS-INC-8290/news/Sector-Update-Health-Care-Stocks-Slipping-Late-Afternoon-46426659/

Analyst Ratings
Piper Sandler Overweight Apr 16, 24
Stifel Buy Apr 2, 24
Piper Sandler Overweight Feb 20, 24
Barclays Overweight Feb 14, 24
Goldman Sachs Buy Jan 17, 24
Piper Sandler Overweight Nov 6, 23
Stifel Buy Oct 30, 23
Stifel Buy Sep 12, 23
HSBC Buy Sep 6, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lagano Roxanne Executive Vice Presi.. Executive Vice President Jan 18 Sell 191.43 923 176,690 17,569 01/19/24
Lagano Roxanne Executive Vice Presi.. Executive Vice President Dec 14 Sell 200 2,500 500,000 19,415 12/14/23
Lagano Roxanne Executive Vice Presi.. Executive Vice President Sep 01 Sell 192.97 923 178,111 25,434 09/05/23
Lagano Roxanne Executive Vice Presi.. Executive Vice President Apr 18 Sell 175.94 4,338 763,228 26,357 04/19/23
Lagano Roxanne Executive Vice Presi.. Executive Vice President Apr 18 Option 80.38 4,338 348,688 30,695 04/19/23
Lagano Roxanne Executive Vice Presi.. Executive Vice President Jul 22 Option 80.38 2,167 174,183 25,854 07/26/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Jul 22 Sell 180.26 2,167 390,623 23,687 07/26/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Jun 27 Option 80.38 4,334 348,367 28,021 06/28/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Jun 27 Sell 175 4,334 758,450 23,687 06/28/22
Reed Willie M Director Director Jun 10 Sell 162.31 1,855 301,085 6,782 06/13/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Apr 26 Option 80.38 2,167 174,183 25,854 04/28/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Apr 26 Sell 178.96 2,167 387,806 23,687 04/28/22
PECK KRISTIN C Chief Executive Offi.. Chief Executive Officer Feb 25 Option 30.89 10,000 308,900 49,743 02/28/22
PECK KRISTIN C Chief Executive Offi.. Chief Executive Officer Feb 25 Sell 192.25 10,000 1,922,500 39,743 02/28/22
David Glenn Executive Vice Presi.. Executive Vice President Feb 23 Option 66.8 32,390 2,163,652 78,962 02/24/22
David Glenn Executive Vice Presi.. Executive Vice President Feb 23 Sell 189.87 32,390 6,149,889 46,572 02/24/22
Lagano Roxanne Executive Vice Presi.. Executive Vice President Feb 15 Sell 196.54 2,065 405,855 23,687 02/16/22
Chen Heidi C. Executive Vice Presi.. Executive Vice President Nov 09 Option 73.24 9,446 691,825 33,541 11/10/21
Chen Heidi C. Executive Vice Presi.. Executive Vice President Nov 09 Sell 220 9,446 2,078,120 24,095 11/10/21
Chen Heidi C. Executive Vice Presi.. Executive Vice President Oct 25 Option 73.24 9,446 691,825 33,541 10/26/21
Chen Heidi C. Executive Vice Presi.. Executive Vice President Oct 25 Sell 210.22 9,446 1,985,738 24,095 10/26/21
Lagano Roxanne Executive Vice Presi.. Executive Vice President Aug 24 Sell 207.02 9,603 1,988,013 22,874 08/24/21
SCULLY ROBERT W Director Director Feb 23 Buy 164.72 7,590 1,250,225 7,590 02/23/21
Alaix Juan Ramon Director Director Feb 23 Option 73.24 133,070 9,746,047 347,377 02/23/21
Alaix Juan Ramon Director Director Feb 23 Sell 160.94 133,070 21,416,286 214,307 02/23/21
Trawicki Roman Executive Vice Presi.. Executive Vice President Feb 18 Option 73.24 3,285 240,593 8,114 02/18/21
Trawicki Roman Executive Vice Presi.. Executive Vice President Feb 18 Sell 165.82 4,491 744,698 3,623 02/18/21
PECK KRISTIN C Chief Executive Offi.. Chief Executive Officer Nov 25 Option 30.89 6,500 200,785 38,374 11/25/20
PECK KRISTIN C Chief Executive Offi.. Chief Executive Officer Nov 25 Sell 161.72 10,500 1,698,060 27,874 11/25/20
Lagano Roxanne Executive Vice Presi.. Executive Vice President Nov 20 Option 41.83 6,000 250,980 41,680 11/20/20
Trawicki Roman Executive Vice Presi.. Executive Vice President Oct 02 Option 55.02 4,080 224,482 5,501 10/02/20
Trawicki Roman Executive Vice Presi.. Executive Vice President Oct 02 Sell 165.65 5,501 911,241 10/02/20